Filter By Industry
Filter By Tag

Newsroom

Huateng Pharma Press releases

31 - 40 of 44 Press Releases

May 13, 2021
Lipid nanoparticles have been developed as vehicles for small molecule delivery by the nanomedicine and materials communities and are now a key component of COVID-19 mRNA vaccines. Vaccines against COVID-19 have been developed with unprecedented speed.

Apr 22, 2021
This group sought to determine if the evolution of insulin in vertebrates - including humans -- has encountered a roadblock. Has a complex series of steps imposed constraints that have frozen the sequence of insulin at a precipice of non-foldability?

Mar 30, 2021
Scientists have discovered a route of introduction for High Pathogenicity Avian Influenza Virus (HPAIV) H5N8 into Japan and, in parallel, have investigated the potential of two human anti-influenza drugs for the control of HPAI in birds.

Mar 01, 2021
Genetically determined vitamin D levels do not have a large effect on risk of type 1 diabetes in Europeans, according to a study published 25th February 2021 in the open-access journal PLOS Medicine by Despoina Manousaki from the CHU Sainte Justine and...

Jan 29, 2021
In 2018 and 2019, the German Institute for Quality and Efficiency in Health Care (IQWiG) already investigated whether the drug enzalutamide has an advantage in comparison with the appropriate comparator therapy, i.e.

Dec 24, 2020
Scientists have shown that adding an experimental cancer drug to a widely used diabetes treatment improves blood sugar control and weight loss in mice, according to a study published on 22nd, Dec. in eLife.

Nov 23, 2020
In a form of cancer known as ALK-rearranged non-small-cell lung cancer (NSCLC), CNS metastasis is known to persist when drugs targeting primary tumors are used.

Oct 21, 2020
A research team led by Professor Hongzhe SUN, Norman & Cecilia Yip Professor in Bioinorganic Chemistry, has discovered a novel antiviral strategy for treatment of COVID-19.

Sep 17, 2020
LAROTRECTINIB APPROVED FOR SOLID TUMORS WITH NTRK MUTATION On November 26, 2018,FDA approved larotrectinib (Vitrakvi; Loxo Oncology), the first drug approved for the treatment of adults and pediatric patients with solid tumors that have an NTRK gene...

Aug 18, 2020
This is a remarkable, massive, multinational study that has provided insights that can inform patient choices about hypertension treatment.


Page: Prev 1 2 3 4 5 Next
Huateng Pharma RSS Feed